SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales declined to Rs. 19119.30 millions for the June 2022 quarter as compared to Rs. 21421.17 millions during the corresponding quarter last year.Net profit for the quarter ended June 2022 increases to Rs. 4925.81  millions from Rs. 4894.15 millions.OP of the company witnessed a marginal growth to 7803.42 millions from 6948.56 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 19119.30 21421.17 -10.75 19119.30 21421.17 -10.75 81415.81 75679.33 7.58
Other Income 3465.18 1382.08 150.72 3465.18 1382.08 150.72 6146.28 3962.37 55.12
PBIDT 7803.42 6948.56 12.30 7803.42 6948.56 12.30 23028.49 22865.78 0.71
Interest 397.63 590.15 -32.62 397.63 590.15 -32.62 2360.41 2658.98 -11.23
PBDT 7405.79 6358.41 16.47 7405.79 6358.41 16.47 24971.41 20945.72 19.22
Depreciation 450.33 374.42 20.27 450.33 374.42 20.27 1596.95 1508.15 5.89
PBT 6955.46 5983.99 16.23 6955.46 5983.99 16.23 23374.46 19437.57 20.25
TAX 2029.65 1089.84 86.23 2029.65 1089.84 86.23 3396.57 2943.10 15.41
Deferred Tax 926.08 38.95 2277.61 926.08 38.95 2277.61 -714.21 -493.08 44.85
PAT 4925.81 4894.15 0.65 4925.81 4894.15 0.65 19977.89 16494.47 21.12
Equity 282.17 282.17 0.00 282.17 282.17 0.00 282.17 282.17 0.00
PBIDTM(%) 40.81 32.44 25.82 40.81 32.44 25.82 28.29 30.21 -6.38

Glenmark Pharma Share Price

2307.65 -29.55 (-1.26%)
24-Apr-2026 13:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1621.00
Dr. Reddys Lab 1320.30
Cipla 1297.40
Zydus Lifesciences 930.10
Lupin 2279.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×